Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy

被引:0
|
作者
Goudarzi, Mohammad Taghi Hedayati [1 ]
Moradi, Maryam [2 ]
Abrotan, Saeed [1 ]
Saravi, Mehrdad [2 ]
Shirafkan, Hoda [3 ]
Irilouzadian, Rana [4 ]
Omran, Hossein Salehi [1 ]
机构
[1] Babol Univ Med Sci, Rohani Hosp, Sch Med, Dept Cardiol, Babol, Iran
[2] Babol Univ Med Sci, Fac Med, Dept Cardiol, Babol, Iran
[3] Babol Univ Med Sci, Hlth Res Inst, Social Determinants Hlth Res Ctr, Babol, Iran
[4] Iran Univ Med Sci, Burn Res Ctr, Tehran, Iran
关键词
SUDDEN-DEATH; TASK-FORCE; THERAPY; POPULATION; PREVENTION; EFFICACY; OUTCOMES; SOCIETY;
D O I
10.1155/2023/4552100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Hypertrophic cardiomyopathy (HCM) has different complications such as cardiac arrhythmia and sudden cardiac death (SCD). Insertion of an implantable cardioverter defibrillator (ICD) is recommended for HCM patients who are at high risk of SCD and malignant arrhythmias, despite having their own potential complications. Hypothesis. We aimed to investigate the prevalence of different complications of ICD insertion and the impact of the potential influential baseline characteristics in a one-year follow-up period. Methods. This was a retrospective study with a total of 71 HCM patients with ICD insertion. We evaluated the prevalence of different complications of ICD implantation and the impact of baseline characteristics on the occurrence of ICD complications using multivariate regression analysis in three 4-month periods. Results. In a one-year follow-up, 13 patients (18.3%) experienced at least one of the complications including pneumothorax, lead failure, ICD infection, inappropriate shocks, perforation, and upper limb deep vein thrombosis (DVT) with no mortality. Inappropriate shocks were reported as the most common (11.3%) complication during this period, with a gradual increase in the second (4.2%) and third (5.6%) follow-up sessions. Among all of the baseline characteristics that were investigated in this study, a positive history of hypertension was the only risk factor with significant impact on the occurrence of complications (P = 0.01). Conclusion. We demonstrated the occurrence of complications during a one-year follow-up as 18.3% in HCM patients with ICD insertion. A positive history of hypertension was the only baseline characteristic affecting the occurrence of complications, and inappropriate shocks were the most common complication.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Living with hypertrophic cardiomyopathy and an implantable defibrillator
    Magnusson, Peter
    Jonsson, Jessica
    Morner, Stellan
    Fredriksson, Lennart
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [32] Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy
    Christensen, Alex Horby
    Platonov, Pyotr G.
    Svensson, Anneli
    Jensen, Henrik K.
    Rootwelt-Norberg, Christine
    Dahlberg, Pia
    Madsen, Trine
    Frederiksen, Tanja Charlotte
    Helio, Tiina
    Haugaa, Kristina H.
    Bundgaard, Henning
    Svendsen, Jesper H.
    EUROPACE, 2022, 24 (02): : 306 - 312
  • [33] Sex and Race Disparities in Hypertrophic Cardiomyopathy: Unequal Implantable Cardioverter-Defibrillator Use During Hospitalization
    Patlolla, Sri Harsha
    Schaff, Hartzell, V
    Nishimura, Rick A.
    Geske, Jeffrey B.
    Dunlay, Shannon M.
    Ommen, Steve R.
    MAYO CLINIC PROCEEDINGS, 2022, 97 (03) : 507 - 518
  • [34] Earlymortality after implantable cardioverter defibrillator: Incidence and associated factors
    Garcia, Rodrigue
    Boveda, Serge
    Defaye, Pascal
    Sadoul, Nicolas
    Narayanan, Kumar
    Perier, Marie-Cecile
    Klug, Didier
    Fauchier, Laurent
    Leclercq, Christophe
    Babuty, Dominique
    Bordachar, Pierre
    Gras, Daniel
    Deharo, Jean-Claude
    Piot, Olivier
    Providencia, Rui
    Marijon, Eloi
    Algalarrondo, Vincent
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 301 : 114 - 118
  • [35] Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillation
    Park, Yae Min
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2022, : 7 - 15
  • [37] Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy
    Maurizi, Niccolo'
    Olivotto, Iacopo
    Nordkamp, Louise R. A. Olde
    Baldini, Katia
    Fumagalli, Carlo
    Brouwer, Tom F.
    Knops, Reinoud E.
    Cecchi, Franco
    HEART RHYTHM, 2016, 13 (02) : 457 - 463
  • [38] Subcutaneous versus transvenous implantable defibrillator in patients with hypertrophic cardiomyopathy
    Jankelson, Lior
    Garber, Leonid
    Sherrid, Mark
    Massera, Daniele
    Jones, Paul
    Barbhaiya, Chirag
    Holmes, Douglas
    Knotts, Robert
    Bernstein, Scott
    Spinelli, Michael
    Park, David
    Aizer, Anthony
    Chinitz, Larry
    HEART RHYTHM, 2022, 19 (05) : 759 - 767
  • [39] Recurrent Implantable Cardioverter-Defibrillator Replacement Is Associated with an Increasing Risk of Pocket-Related Complications
    Borleffs, C. Jan Willem
    Thijssen, Joep
    de Bie, Mihaly K.
    van Rees, Johannes B.
    van Welsenes, Guido H.
    van Erven, Lieselot
    Bax, Jeroen J.
    Cannegieter, Suzanne C.
    Schalij, Martin J.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2010, 33 (08): : 1013 - 1019
  • [40] Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study
    Balaji, Seshadri
    DiLorenzo, Michael P.
    Fish, Frank A.
    Etheridge, Susan P.
    Aziz, Peter F.
    Russell, Mark W.
    Tisma, Svjetlana
    Pflaumer, Andreas
    Sreeram, Narayanswami
    Kubus, Peter
    Law, Ian H.
    Kantoch, MichalJ
    Kertesz, Naomi J.
    Strieper, Margaret
    Erickson, Christopher C.
    Moore, Jeremy P.
    Nakano, Stephanie J.
    Singh, Harinder R.
    Chang, Philip
    Cohen, Mitchell
    Fournier, Anne
    Ilina, Maria, V
    Smith, Richard T.
    Zimmerman, Frank
    Horndasch, Michaela
    Li, Walter
    Batra, Anjan
    Liberman, Leonardo
    Hamilton, Robert
    Janson, Christopher M.
    Sanatani, Shubhayan
    Zeltser, Ilana
    McDaniel, George
    Blaufox, Andrew D.
    Garnreiter, Jason M.
    Katcoff, Hannah
    Shah, Maully
    HEART RHYTHM, 2019, 16 (10) : 1462 - 1467